Rachel Miller – Projects & Grants — University of Kentucky

Research activity per year

5 Active
25 Finished

5 results

Filter

Active
GOG-3091: A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive, Recurrent or Metastatic Cerv
Miller, R.
Gynecological Oncology Group Foundation Incorporated
5/14/24 → 5/14/26
Project: Research project
IMGN853-0421/GOG-3078: Randomized, Multicenter, Open-label, Phase 3 study of Mirvetuximab Soravtansine in Combination with Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients with FRa-positive Recurrent Platinum-sensitive Epithelial o
Miller, R.
ImmunoGen Inc
8/30/23 → 8/30/25
Project: Research project
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-Mutated Advanced Epithelial Ovarian Cancer (EOC)
Miller, R.
Gynecological Oncology Group Foundation Incorporated
2/27/20 → 8/24/25
Project: Research project
A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel in Patients with Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Miller, R.
Gynecological Oncology Group Foundation Incorporated
11/15/19 → 1/16/25
Project: Research project
Member Institution Purchased Service Agreement
Miller, R. & Romond, E.
NRG Oncology Foundation Incorporated
3/1/14 → 1/4/25
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.